GlobalData''s clinical trial report, “Bone Metastasis Global Clinical Trials Review, H1, 2013" provides data on the Bone Metastasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Metastasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bone Metastasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData''s team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Buy a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215426
Table of Contents
List of Tables 5
List of Figures 6
Introduction 7
Bone Metastasis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Bone Metastasis 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Bone Metastasis Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Algeta ASA 34
Clinical Trial Overview of Algeta ASA 34
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Amgen Inc. 36
Clinical Trial Overview of Amgen Inc. 36
Merck & Co., Inc. 37
Clinical Trial Overview of Merck & Co., Inc. 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Hoffmann-La Roche Inc. 39
Clinical Trial Overview of Hoffmann-La Roche Inc. 39
Novartis Pharmaceuticals Corporation 40
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 40
Bayer AG 41
Clinical Trial Overview of Bayer AG 41
Medivir AB 42
Clinical Trial Overview of Medivir AB 42
Insmed Incorporated 43
Clinical Trial Overview of Insmed Incorporated 43
Merck KGaA 44
Clinical Trial Overview of Merck KGaA 44
Galil Medical Ltd. 45
Clinical Trial Overview of Galil Medical Ltd. 45
AstraZeneca PLC 46
Clinical Trial Overview of AstraZeneca PLC 46
Celsion Corporation 47
Clinical Trial Overview of Celsion Corporation 47
Bristol-Myers Squibb Company 48
Clinical Trial Overview of Bristol-Myers Squibb Company 48
Clinical Trial Overview of Top Universities / Institutes / Hospitals 49
The University of Texas M. D. Anderson Cancer Center 49
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 49
Sun Yat-sen University 50
Clinical Trial Overview of Sun Yat-sen University 50
University Health Network 51
Clinical Trial Overview of University Health Network 51
Memorial Sloan Kettering Cancer Center 52
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 52
Massachusetts General Hospital 53
Clinical Trial Overview of Massachusetts General Hospital 53
UMC Utrecht Holding BV 54
Clinical Trial Overview of UMC Utrecht Holding BV 54
Virginia Commonwealth University 55
Clinical Trial Overview of Virginia Commonwealth University 55
Rambam Health Care Campus 56
Clinical Trial Overview of Rambam Health Care Campus 56
Wake Forest University 57
Clinical Trial Overview of Wake Forest University 57
University of Virginia 58
Clinical Trial Overview of University of Virginia 58
FUDAN University 59
Clinical Trial Overview of FUDAN University 59
The University of British Columbia 60
Clinical Trial Overview of The University of British Columbia 60
VU University Medical Center 61
Clinical Trial Overview of VU University Medical Center 61
The University of Texas Health Science Center at San Antonio 62
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 62
National Taiwan University Hospital 63
Clinical Trial Overview of National Taiwan University Hospital 63
Case Comprehensive Cancer Center 64
Clinical Trial Overview of Case Comprehensive Cancer Center 64
Sunnybrook Health Sciences Centre 65
Clinical Trial Overview of Sunnybrook Health Sciences Centre 65
University of Michigan 66
Clinical Trial Overview of University of Michigan 66
Chinese University of Hong Kong 67
Clinical Trial Overview of Chinese University of Hong Kong 67
Queen''s University 68
Clinical Trial Overview of Queen''s University 68
Five Key Clinical Profiles 69
Appendix 142
Abbreviations 142
Definitions 142
Research Methodology 143
Secondary Research 144
About GlobalData 144
Contact Us 144
Disclaimer 144
Source 145
Request a Sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215426
Table of Contents
List of Tables 5
List of Figures 6
Introduction 7
Bone Metastasis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Bone Metastasis 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Bone Metastasis Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Algeta ASA 34
Clinical Trial Overview of Algeta ASA 34
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Amgen Inc. 36
Clinical Trial Overview of Amgen Inc. 36
Merck & Co., Inc. 37
Clinical Trial Overview of Merck & Co., Inc. 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Hoffmann-La Roche Inc. 39
Clinical Trial Overview of Hoffmann-La Roche Inc. 39
Novartis Pharmaceuticals Corporation 40
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 40
Bayer AG 41
Clinical Trial Overview of Bayer AG 41
Medivir AB 42
Clinical Trial Overview of Medivir AB 42
Insmed Incorporated 43
Clinical Trial Overview of Insmed Incorporated 43
Merck KGaA 44
Clinical Trial Overview of Merck KGaA 44
Galil Medical Ltd. 45
Clinical Trial Overview of Galil Medical Ltd. 45
AstraZeneca PLC 46
Clinical Trial Overview of AstraZeneca PLC 46
Celsion Corporation 47
Clinical Trial Overview of Celsion Corporation 47
Bristol-Myers Squibb Company 48
Clinical Trial Overview of Bristol-Myers Squibb Company 48
Clinical Trial Overview of Top Universities / Institutes / Hospitals 49
The University of Texas M. D. Anderson Cancer Center 49
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 49
Sun Yat-sen University 50
Clinical Trial Overview of Sun Yat-sen University 50
University Health Network 51
Clinical Trial Overview of University Health Network 51
Memorial Sloan Kettering Cancer Center 52
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 52
Massachusetts General Hospital 53
Clinical Trial Overview of Massachusetts General Hospital 53
UMC Utrecht Holding BV 54
Clinical Trial Overview of UMC Utrecht Holding BV 54
Virginia Commonwealth University 55
Clinical Trial Overview of Virginia Commonwealth University 55
Rambam Health Care Campus 56
Clinical Trial Overview of Rambam Health Care Campus 56
Wake Forest University 57
Clinical Trial Overview of Wake Forest University 57
University of Virginia 58
Clinical Trial Overview of University of Virginia 58
FUDAN University 59
Clinical Trial Overview of FUDAN University 59
The University of British Columbia 60
Clinical Trial Overview of The University of British Columbia 60
VU University Medical Center 61
Clinical Trial Overview of VU University Medical Center 61
The University of Texas Health Science Center at San Antonio 62
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 62
National Taiwan University Hospital 63
Clinical Trial Overview of National Taiwan University Hospital 63
Case Comprehensive Cancer Center 64
Clinical Trial Overview of Case Comprehensive Cancer Center 64
Sunnybrook Health Sciences Centre 65
Clinical Trial Overview of Sunnybrook Health Sciences Centre 65
University of Michigan 66
Clinical Trial Overview of University of Michigan 66
Chinese University of Hong Kong 67
Clinical Trial Overview of Chinese University of Hong Kong 67
Queen''s University 68
Clinical Trial Overview of Queen''s University 68
Five Key Clinical Profiles 69
Appendix 142
Abbreviations 142
Definitions 142
Research Methodology 143
Secondary Research 144
About GlobalData 144
Contact Us 144
Disclaimer 144
Source 145
Request a Sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215426
